NOV 03, 2019 08:53 AM PST

Can CRISPR Replace Antibiotics?

WRITTEN BY: Annie Lennon

Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019). Although some have thus called for the development of new antibiotics, researchers are now finding that CRISPR technology may hold a better solution. 

Aside from leading to antibiotic resistance from excessive usage, conventional antibiotics are known to act indiscriminately. Although they eradicate pathogens, they often eradicate healthy microbiota too. The eradication of this microbiota by many antibiotics has been shown to lead to further health issues including metabolic illnesses, cancer, mental health issues and neurodegenerative diseases (Leitch: 2019).  

Unlike antibiotics however, with CRISPR, researchers are able to specifically target pathogenic bacteria and leave healthy microbes alone by engineering each CRISPR vehicle to target only one kind of pathogen. And already, preliminary tests have yielded positive results. 

In a study by the Broad Institute of MIT and Harvard, researchers were able to use CRISPR enzyme, Cas13, to detect and kill three different single-stranded RNA viruses: influenza A virus, lymphocytic choriomeningitis virus and vesicular stomatitis virus (Freije: 2019). A great proof-of-concept, given CRISPR’s efficacy in treating these relatively mild human viruses, researchers feel it is likely that the technology may be modified to treat more deadly infections too. 

Another advantage CRISPR holds over conventional antibiotics is that it can be easily tweaked when needed, meaning treatments are better able to keep up with frequent viral mutations that increasingly render antibiotics ineffective. According to Cameron Myhrvold, a postdoctoral researcher at the Broad Institute, “If a virus evolves and mutates, we can simply change the Crispr system to match whatever the virus is doing (Sheikh: 2019).”

Yet, despite promise in the technology and exciting early results, researchers have warned that we are still a long way from being able to take CRISPR pills to oust viruses. With experiments so far having been done in petri dishes or via computational models, the next step for researchers is thus to see whether CRISPR treatments show the same results in living animals and humans, and of course, whether they can be made cheaper than conventional therapies (ibid.). 


 

Sources 

 

Jacobs, Andrew: New York Times  

Leitch, Carmen: Labroots

Freije, Catherine A.: Molecular Cell

Sheikh, Knvul: New York Times

 

About the Author
  • Writer with a keen interest in genetics, psychology, health and everything in between. Currently focused on the interplay of genetics and society to understand how to create meaningful interactions and environments.
You May Also Like
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Dolphins Lost 85 Genes to Become Aquatic
Dolphins, whales and porpoises are marine mammals; otherwise known as cetaceans. Although they live exclusively underwater nowadays, tens of millions of ye...
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Gaining New Insight Into ALS and Other Neurodegenerative Disorders
Scientists have now used a technique called deep mutagenesis to reveal more about amyotrophic lateral sclerosis....
DEC 10, 2019
Microbiology
DEC 10, 2019
Probiotics Linked to Bloodstream Infections in ICU Patients
Probiotics, which are live microbes, are intended to improve human health, and they are sometimes given to intensive care unit patients of all ages....
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
FDA Approves New Drug for Sickle Cell Disease
Sickle cell disease affects approximately 100,000 Americans. Currently, the only available cure for the disease is a costly bone marrow transplant, putting...
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
Loading Comments...